Testing effectiveness (Phase 2)UnknownNCT05266196
What this trial is testing
A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577)
Who this might be right for
Ewing SarcomaMyxoid LiposarcomaDesmoplastic Small Round Cell Tumor+6 more
Salarius Pharmaceuticals, LLC 10